Toronto Dominion Bank’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,360
Closed -$4.75M 1647
2022
Q3
$4.75M Sell
19,360
-2,325
-11% -$628K 0.01% 684
2022
Q2
$5.37M Sell
21,685
-988
-4% -$267K 0.01% 562
2022
Q1
$7.51M Buy
22,673
+95
+0.4% +$29.2K 0.01% 525
2021
Q4
$8.11M Buy
22,578
+1,505
+7% +$508K 0.01% 560
2021
Q3
$6.86M Buy
21,073
+1,220
+6% +$413K 0.01% 535
2021
Q2
$6.2M Sell
19,853
-2,204
-10% -$676K 0.01% 560
2021
Q1
$7.03M Sell
22,057
-4,398
-17% -$1.41M 0.01% 520
2020
Q4
$8.58M Buy
26,455
+1,067
+4% +$295K 0.02% 474
2020
Q3
$7.03M Sell
25,388
-4,152
-14% -$1.2M 0.02% 452
2020
Q2
$7.14M Sell
29,540
-4,558
-13% -$915K 0.02% 513
2020
Q1
$4.95M Sell
34,098
-7,506
-18% -$1.25M 0.02% 498
2019
Q4
$7.1M Buy
41,604
+8,232
+25% +$1.53M 0.01% 561
2019
Q3
$5.94M Sell
33,372
-31,182
-48% -$6.74M 0.01% 604
2019
Q2
$8.41M Buy
64,554
+27,003
+72% +$7.16M 0.02% 554
2019
Q1
$10.7M Buy
37,551
+10,380
+38% +$3.45M 0.02% 470
2018
Q4
$8.83M Sell
27,171
-1,713
-6% -$595K 0.02% 454
2018
Q3
$13M Buy
28,884
+1,741
+6% +$686K 0.02% 383
2018
Q2
$11.1M Buy
+27,143
New +$9.83M 0.02% 423

Other funds holding ABMD

Toronto Dominion Bank's ABMD Position: Q4 2022 in Review

Toronto Dominion Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 19,360 shares — an estimated $4.75M sold.

Toronto Dominion Bank first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $13M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Toronto Dominion Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 19,360 Abiomed Inc shares in Q4 2022, an estimated $4.75M.
  • Toronto Dominion Bank first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Toronto Dominion Bank's Abiomed Inc position peaked at $13M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Toronto Dominion Bank's 13F filing for Q4 2022, filed 7 Feb 2023.